CCL Industries (CCL-B) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
9 Jul, 2026Executive summary
Third quarter 2024 sales rose 9.4% year-over-year to $1,849.7 million, driven by 6.9% organic growth, 1.8% from acquisitions, and 0.7% positive FX impact.
Operating income increased 13% year-over-year (excluding FX), reaching $288.9 million, with a 15.6% margin, up 50 bps year-over-year.
Net earnings for Q3 2024 were $191.7 million, up from $169.1 million in Q3 2023; nine-month net earnings were $663.3 million, including a $78.1 million non-taxable revaluation gain.
Adjusted basic EPS for Q3 was $1.09, up 14.7% year-over-year; nine-month adjusted EPS was $3.30.
Nine acquisitions since January 2023 contributed 2.6% to nine-month sales growth.
Financial highlights
Adjusted EBITDA for Q3 2024 was $380.7 million, up 11% year-over-year; nine-month Adjusted EBITDA was $1,135.5 million.
Free cash flow from operations was $233 million in Q3 2024, up from $182 million in Q3 2023; nine-month free cash flow was $344.8 million.
Basic EPS for Class B shares was $1.08; adjusted EPS was $1.09, up 14.7% year-over-year.
Net finance expense decreased to $19.3 million from $20.3 million year-over-year.
Effective tax rate was 24.5% for Q3 and 22.3% for the nine months.
Outlook and guidance
Q4 faces higher hurdles due to tough comps and new plant startup costs, but October started better than expected.
CCL Design faces tougher comps as the automotive industry slows; CCL Secure expected to improve sequentially.
Avery performance expected to remain stable; Checkpoint RFID and Innovia recovery to continue.
FX expected to be a modest tailwind at current rates.
CCL segment faces tougher year-over-year comparisons amid uncertain geopolitical and consumer environments.
Latest events from CCL Industries
- Q3 sales and EPS rose, cash flow was strong, and $467.9M was returned to shareholders.CCL-B
Q3 20259 Jul 2026 - Q2 2024 saw double-digit sales and profit growth, led by RFID and a major acquisition gain.CCL-B
Q2 20248 Jul 2026 - Sales up 2.8%, adjusted EPS rose, and cash flow strong despite inflationary headwinds.CCL-B
Q1 202614 May 2026 - Record 2025 sales, earnings, and cash flow drove higher shareholder returns and stable 2026 outlook.CCL-B
Q4 202526 Feb 2026 - Q1 2025 saw record sales, earnings, and cash flow, with robust shareholder returns.CCL-B
Q1 20258 Jan 2026 - Record 2024 sales and earnings, strong cash flow, and positive but cautious 2025 outlook.CCL-B
Q4 20248 Jan 2026 - Q2 2025 saw record adjusted EPS, strong cash flow, and robust shareholder returns despite tariff headwinds.CCL-B
Q2 202523 Nov 2025